ZY Zymergen Inc.

Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.

$1.20  -0.03 (-2.44%)
As of 07/01/2022 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Materials
Industry:  Chemicals
Index country:  USA
Country of incorporation:  USA
IPO date:  04/22/2021
Outstanding shares:  103,140,755
Average volume:  1,910,096
Market cap:   $126,863,129
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMF1M49

---

Valuation   (See tab for details)

---

PE ratio:   -0.35
PB ratio:   0.36
PS ratio:   7.22
Return on equity:   -101.50%
Net income %:   -1,988.46%